Trials / Unknown
UnknownNCT02993809
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- South China Research Center for Stem Cell and Regenerative Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The intent of this clinical study is to evaluate the safety of the injection composed of autologous bone marrow derived endothelial cells (BM-ECs) and platelet-rich plasma extract (PRPE) for the treatment of critical limb ischemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | BM-ECs and PRPE | |
| BIOLOGICAL | BM-ECs |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2019-12-01
- First posted
- 2016-12-15
- Last updated
- 2016-12-15
Source: ClinicalTrials.gov record NCT02993809. Inclusion in this directory is not an endorsement.